Skip to main content

Lebwohl David's Form 4 filing

Intellia Therapeutics, Inc. (NTLA) · filed Mar 3, 2022

Accession no.
0001209191-22-015960
Filed
Mar 3, 2022
Trade date
Jan 1-Mar 1, 2022
Filing delay
61 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $118.0K. It was filed 61 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001209191-22-016533 (Mar 4, 2022). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lebwohl DavidCIK 0001810882Officer (EVP, Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 1, 2022Common StockMOption exerciseAcquired+3,187–F1–11,973Direct
Jan 1, 2022Common StockSSaleDisposed−1,051$112.24−$117,964.2410,922Direct
Mar 1, 2022Common StockAGrant or awardAcquired+13,816$0.00$024,738Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 1, 2022Common StockMOption exerciseDisposed−3,187$0.00$09,563Direct
Mar 1, 2022Common StockAGrant or awardAcquired+13,816$0.00$013,816Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)